GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Shiller PE Ratio

Mendus AB (OSTO:IMMU) Shiller PE Ratio : (As of Apr. 27, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mendus AB Shiller PE Ratio Historical Data

The historical data trend for Mendus AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Shiller PE Ratio Chart

Mendus AB Annual Data
Trend Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mendus AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mendus AB's Shiller PE Ratio

For the Biotechnology subindustry, Mendus AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mendus AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mendus AB's Shiller PE Ratio falls into.


;
;

Mendus AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mendus AB's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Mendus AB's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.63/132.9872*132.9872
=-0.630

Current CPI (Dec. 2024) = 132.9872.

Mendus AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -22.984 99.950 -30.581
201506 -6.442 99.995 -8.567
201509 -6.688 100.228 -8.874
201512 -15.874 100.276 -21.052
201603 -23.811 100.751 -31.429
201606 -9.922 101.019 -13.062
201609 -7.889 101.138 -10.373
201612 -18.226 102.022 -23.758
201703 -13.720 102.022 -17.884
201706 -12.691 102.752 -16.425
201709 -14.234 103.279 -18.328
201712 -16.461 103.793 -21.091
201803 -11.053 103.962 -14.139
201806 -7.369 104.875 -9.344
201809 -9.211 105.679 -11.591
201812 -9.211 105.912 -11.566
201903 -5.526 105.886 -6.940
201906 -6.632 106.742 -8.263
201909 -5.895 107.214 -7.312
201912 6.448 107.766 7.957
202003 -2.947 106.563 -3.678
202006 -3.316 107.498 -4.102
202009 -4.053 107.635 -5.008
202012 -11.237 108.296 -13.799
202103 -4.605 108.360 -5.652
202106 -3.500 108.928 -4.273
202109 -2.395 110.338 -2.887
202112 -3.132 112.486 -3.703
202203 -2.579 114.825 -2.987
202206 -2.763 118.384 -3.104
202209 -3.800 122.296 -4.132
202212 -4.400 126.365 -4.631
202303 -3.000 127.042 -3.140
202306 -0.020 129.407 -0.021
202309 -0.050 130.224 -0.051
202312 -0.950 131.912 -0.958
202403 -0.800 132.205 -0.805
202406 -0.760 132.716 -0.762
202409 -0.460 132.304 -0.462
202412 -0.630 132.987 -0.630

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mendus AB  (OSTO:IMMU) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mendus AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mendus AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mendus AB Business Description

Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB Headlines

From GuruFocus

Immunomedics: A Solid Cancer Research Play

By Ishan Majumdar Ishan Majumdar 07-08-2020